With an eye on ‘underserved’ Nordic biotechs, Eir raises €76M toward first fund

The new firm believes Scandinavia offers high-quality science in a market with few dedicated VCs

Newly launched Eir Ventures believes the Nordic countries offer an investment opportunity rich in science that has been underserved by VCs. To help fill the gap, the firm has raised the first €76 million ($85.5 million) toward its first fund, which Eir hopes will top out at about €100

Read the full 493 word article

How to gain access

Continue reading with a
two-week free trial.